Gilead Sciences (GILD) cash on hand

Cash · fiscal 2025
$9.61B

Gilead Sciences (GILD) held cash of $9.61B at the end of fiscal 2025 (December 31, 2025). That is 16.9% lower than the $11.57B of fiscal 2024. Figures as of 18 Nov 2026, 11:26 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$9.61B
Change on fiscal 2024
−16.9%
Highest on record
$11.57Bfiscal 2024
Lowest on record
$6.39Bfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Gilead Sciences cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $11.57B in fiscal 2024 and the lowest $6.39B in fiscal 2022.

History · 4 fiscal years

Cash by fiscal year

Gilead Sciences cash on hand, year by year

Gilead Sciences (GILD) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$9.61B 16.9% down
2024$11.57B 59.3% up
2023$7.26B 13.8% up
2022$6.39B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of Gilead Sciences and comparable companies
CompanyCashFiscal year
Thermo Fisher Scientific TMO$10.11B2025
Amgen AMGN$9.13B2025
Gilead Sciences GILD$9.61B2025
Abbott Laboratories ABT$8.94B2025
Novo Nordisk NVODKK 26.96B2025
Pfizer PFE$13.60B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GILD

Gilead Sciences, figure by figure

Gilead Sciences (GILD) overview: price, valuation and scorecardAll health care companies by market value

Gilead Sciences cash on hand: questions and answers

How much cash does Gilead Sciences have?

Gilead Sciences (GILD) held cash of $9.61B at the end of fiscal 2025 (December 31, 2025). That is 16.9% lower than the $11.57B of fiscal 2024.

What are the highest and lowest cash figures on record for Gilead Sciences?

Across the 4 fiscal years on record (2022–2025), the highest was $11.57B in fiscal 2024 and the lowest $6.39B in fiscal 2022.

How is Gilead Sciences's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone. For Gilead Sciences it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Gilead Sciences (GILD) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/GILD/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.